关注
Antonina Dolgorukova
Antonina Dolgorukova
Valdman Institute of Pharmacology, Pavlov First Saint Petersburg State Medical University, Saint
在 rpharm.ru 的电子邮件经过验证
标题
引用次数
引用次数
年份
Systematic review and meta-analysis of cannabinoids, cannabis-based medicines, and endocannabinoid system modulators tested for antinociceptive effects in animal models of …
N Soliman, S Haroutounian, AG Hohmann, E Krane, J Liao, M Macleod, ...
Pain 162, S26-S44, 2021
1082021
Trace amine-associated receptor 1 modulates the locomotor and sensitization effects of nicotine
I Sukhanov, M Dorofeikova, A Dolgorukova, A Dorotenko, RR Gainetdinov
Frontiers in pharmacology 9, 329, 2018
302018
Activation of trace amine-associated receptor 1 attenuates schedule-induced polydipsia in rats
I Sukhanov, A Dorotenko, A Dolgorukova, MC Hoener, RR Gainetdinov, ...
Neuropharmacology 144, 184-192, 2019
152019
Differential effects of the Piezo1 agonist Yoda1 in the trigeminovascular system: An electrophysiological and intravital microscopy study in rats
A Dolgorukova, JE Isaeva, E Verbitskaya, OA Lyubashina, RА Giniatullin, ...
Experimental Neurology 339, 113634, 2021
132021
The action of TAAR1 agonist RO5263397 on executive functions in rats
A Dorotenko, M Tur, A Dolgorukova, N Bortnikov, IV Belozertseva, ...
Cellular and Molecular Neurobiology 40 (2), 215-228, 2020
122020
The influence of metoclopramide on trigeminovascular nociception: Possible anti-migraine mechanism of action
A Dolgorukova, AV Osipchuk, AA Murzina, AY Sokolov
Neuroscience 425, 123-133, 2020
82020
Activation of trace amine-associated receptor 1 reduces schedule-induced polydipsia in rats
A Dolgorukova, A Dorotenko, L Mus, RR Gainetdinov, I Sukhanov
European Neuropsychopharmacology 27 (S4), 673-673, 2017
52017
Possible approaches to CYP2C9-guided prescription of sulfonylureas in Russia
A Mosikian, A Dolgorukova, A Zalevskaya
Pharmacogenomics 17 (18), 2115-2126, 2016
42016
P. 2.01 Metoclopramide inhibits trigemino-durovascular nociception: implication for migraine
A Dolgorukova, I Vaganova, A Sokolov
European Neuropsychopharmacology 29, S655, 2019
22019
Evaluation of effects of the TAAR1 partial agonist RO5263397 on executive cognitive functions
I Sukhanov, A Dorotenko, N Bortnikov, M Tur, A Dolgorukova, ...
European Neuropsychopharmacology 29, S261-S262, 2019
22019
Meta‐analysis of the effects of anti‐migraine therapeutics in the rat trigeminovascular nociception model as a tool for design optimization
A Dolgorukova, E Protsenko, J Isaeva, V Gagloeva, E Verbitskaya, ...
European Journal of Neuroscience 58 (1), 2339-2360, 2023
12023
Meta-analysis of the effects of clinically-effective therapeutics in the preclinical migraine model as a tool for design optimisation
A Dolgorukova, E Protsenko, J Isaeva, V Gagloeva, E Verbitskaya, ...
bioRxiv, 2022.07. 05.498780, 2022
12022
P. 432 Dural application of the Piezo1 agonist Yoda1 induces dilation of trigeminovascular system-related arteries in rats
A Dolgorukova, JE Isaeva, OA Lyubashina, RА Giniatullin, AY Sokolov
European Neuropsychopharmacology 40, S245-S246, 2020
12020
P. 792 The facilitatory effect of the selective Piezo1 agonist Yoda1 on second-order trigeminovascular neurons in vivo
A Dolgorukova, JE Isaeva, OA Lyubashina, E Verbitskaya, RА Giniatullin, ...
European Neuropsychopharmacology 40, S448-S449, 2020
12020
The trace amine-associated receptor 1 modulates nicotine behavioural effects
I Sukhanov, A Dorotenko, A Dolgorukova, M Dorofeikova, RR Gainetdinov
European Neuropsychopharmacology 27 (S4), 673-674, 2017
12017
The implementation of transcranial Doppler ultrasonography for preclinical study of migraine
A Dolgorukova, AV Potapenko, AA Murzina, OA Lyubashina, A Y. Sokolov
Canadian Journal of Physiology and Pharmacology 100 (6), 553-561, 2022
2022
Characteristics of olokizumab pharmacokinetics in patients with novel coronavirus infection COVID-19
EV Tavlueva, EV Zernova, MP Kutepova, NE Kostina, VS Lesina, ...
Pharmacy & Pharmacology 10 (5), 460-471, 2022
2022
No tolerance to anticompulsive activity of trace amine-associated receptor 1 agonist following repeated administration
A Dorotenko, A Dolgorukova, K Antonova, E Efimova, RR Gainetdinov, ...
European Neuropsychopharmacology 28, S38-S39, 2018
2018
Bioequivalence study of generic nirmatrelvir in healthy volunteers
RA Oseshnyuk, AG Nikiforova, AY Boroduleva, PD Sobolev, ...
系统目前无法执行此操作,请稍后再试。
文章 1–19